Programme
The agenda is available for download here.
Novel Cancer Targets and Emerging Therapies
7:00am – 9:00am Early Registration
7:00am – 9:00am Poster Set Up (The Heritage Atrium, located on the 1st floor of the MaRS Centre)
7:30am – 8:45am Breakfast
8:45am – 9:00am Welcome & Opening Remarks – Dr. Robert Rottapel, MD, FRCPC, TFRI Ontario Node, Toronto &
Mr. Darrell Fox, Board of Directors, TFRI
SESSION I:
9:00am – 9:45am KEYNOTE SPEAKER – Tim Willson, Structural Genomics Consortium, University of North Carolina
Title: Identification of Small Molecules to Shine Light on Dark Kinases
9:45am – 10:10am Speaker – Jim Petrik, PhD, Professor, University of Guelph
Title: Vascular normalization to improve therapeutic efficacy in advanced stage ovarian cancer
10:10am – 10:40am Speaker – Liliana Attisano, PhD, Scientist, Donnelly Centre, University of Toronto
Title: Targeting the Hippo pathway for Therapeutic Intervention
10:40am – 11:05am BREAK
11:05am – 11:35am Speaker – Sheela Abraham, PhD, Scientist, Queen’s Cancer Research Institute
Title: Investigating the Role of Extracellular Vesicles in Hematopoietic Stem Cell Regulation
11:35am – 1:00pm LUNCH & Poster Session (*Judges will review the Posters at this time)
(The Heritage Atrium, located on the 1st floor of the MaRS Centre)
SESSION II:
1:00pm – 1:20pm Speaker – Anton Neschadim, PhD, President & CEO, Immunobiochem Corporation, JLabs @ Toronto
Title: Targeting the Cancer Secretome of Solid Tumors with Potentiated Biologics
1:20pm – 1:45pm Speaker – Rima Al-war, PhD, Director and Senior Scientist, Drug Discovery, Ontario Institute for Cancer Research
Title: Wdr5: The Translational Path of a First-in-Class Therapy for Leukemia
1:45pm – 2:15pm Speaker – Fred Dick, PhD, Professor of Pathology and Oncology, Western University
Title: A CRISPR-Cas9 Based Screen Implicates Netrin Signalling in Cell Survival During Ovarian Cancer Metastasis
2:15pm – 2:45pm Rapid Fire Postdoc Talks – 10 X 3 min
2:45pm –3:05pm BREAK
3:05pm – 3:35pm Speaker – Roman Melnyk, PhD, Senior Scientist, Sickkids
Title: Development of a Potent Ras-Targeted Enzyme for Precision Cancer Therapy
3:35pm – 4:05pm Speaker – Lisa Porter, Director, Windsor Health Institute, University of Windsor
Title: Reinstalling Cell Cycle Checkpoints as a Therapeutic Strategy
4:05pm – 4:50pm KEYNOTE SPEAKER – Professor Craig Crews, Yale University
Title: PROTACs: A New Therapeutic Modality
4:50pm – 5:00pm Closing Remarks
5:00pm – 6:30pm RECEPTION & Poster Session (The Heritage Atrium, located on the 1st floor of the MaRS Centre)
